Literature DB >> 9070922

Human fatty aldehyde dehydrogenase gene (ALDH10): organization and tissue-dependent expression.

C Chang1, A Yoshida.   

Abstract

Mutations in the fatty aldehyde dehydrogenase gene (ALDH10) are responsible for Sjögren-Larsson syndrome (De Laurenzi et al., 1996). In this study, the expression and the genomic organization of the ALDH10 gene are reported. The gene spans approximately 31 kb and consists of 10 exons and 9 introns. All exon-intron junction sequences match the classical GT/AG rule. Both S1 nuclease protection assay and primer extension study suggest that the transcription initiation site is located 195 nucleotides upstream from the ATG codon. No canonical TATA box can be found in the 5'-flanking sequence of the gene, but a CCAAT-like box was found 58 bp upstream of the putative transcription start site. Sequence analysis of the 5'-flanking region revealed numerous potential binding sites for transcription factors Sp1 and AP-2 and one putative HIP-1 binding site. Northern blot analysis of poly(A)+ RNA from various tissues revealed two mRNA species, with sizes around 4.0 and 2.0 kb, that are derived from the differential use of two polyadenylation sites. Although this gene is expressed in a variety of human tissues, the expression level of ALDH10 in the liver and skeletal muscle appears to be higher than that in other tissues examined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070922     DOI: 10.1006/geno.1996.4547

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Molecular basis of Sjögren-Larsson syndrome: frequency of the 1297-1298 del GA and 943C-->T mutation in 29 patients.

Authors:  L Ijlst; W Oostheim; M van Werkhoven; M A Willemsen; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.

Authors:  W B Rizzo; G Carney; Z Lin
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 3.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

Review 4.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

5.  Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.

Authors:  Jessy Etienne; Pierre Joanne; Cyril Catelain; Stéphanie Riveron; Alexandra Clarissa Bayer; Jérémy Lafable; Isabel Punzon; Stéphane Blot; Onnik Agbulut; Jean-Thomas Vilquin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-10       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.